Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in PDF document file format.
  • Where available, URLs for the references have been provided.
  • The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.

Author Guidelines

Manuscript Submission
Articles for publication are to be submitted online

Manuscript preparation FJPAS
Each manuscript shall have the following components among others:

Problem Statement
Materials and Methods

Title page
The title page should contain:
a short informative title that contains not more than 22 words;
the full names and institutional addresses for all the authors;                                                          indicate the corresponding author using an asterisk (*)
the e-mail of the corresponding author.
Note: if a collaboration group should be listed as an author, please list the Group name as an author. If you would like the names of the individual members of the Group to be searchable through their individual PubMed records, please include this information in the “Acknowledgements” section.

The abstract should not exceed 250 words. Please minimize the use of abbreviations and do not cite references in the abstract. The abstract must include the following sub-sections, in a single paragraph:
• Background/Aim: the context and purpose of the study
• Materials and methods: in brief
• Results: the main findings
• Conclusions: summary and potential implications

Five to Six keywords representing the main content of the article and must not be part of the title

This should explain the background to the study, its aims; a summary of the existing literature and why this study was necessary.
Materials and methods
The methods section should include:
• the design and setting of the study
• the characteristics of participants or description of materials
• a clear description of all processes, interventions and comparisons. Generic names should generally be used. When proprietary brands are used in research, include the brand names in parentheses
• the type of statistical analysis used, including a power calculation if appropriate

This should include the findings of the study and if appropriate results of statistical analysis which must be included either in the text or as tables and figures. Also, duplication of results is highly prohibited i.e. presenting the same result in Table and Figure.

For research articles, this section should discuss the implications of the findings in the context of existing research and highlight the limitations of the study. For study protocols and methodology manuscripts, this section should include a discussion of any practical or operational issues involved in performing the study and any issues not covered in other sections.

This should state clearly the main conclusions and explain the importance and relevance of the study to the field.

Note that from the introduction to the conclusion they should have side numbering. Example
1. Introduction
2. Materials and methods (2.1, 2.2. etc. for different subtitles under 2)

List of abbreviations
If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviations should be provided.

All manuscripts must contain the following sections under the heading 'Declarations':
• Ethics approval and consent to participate
• Consent for publication
• Competing interests
• Funding
• Authors' contributions
• Acknowledgements

Ethics approval and consent to participate
Manuscripts reporting studies involving human participants, human data or human tissue must:
• include a statement on ethics approval and consent (even where the need for approval was waived)
• include the name of the ethics committee that approved the study and the committee’s reference number if appropriate
Studies involving animals must include a statement on ethics approval and stating the animal ethics number.
Note: If your manuscript does not report on or involve the use of any animal or human data or tissue, please state “Not applicable” in this section.

Consent for publication
If your manuscript contains any person’s data in any form (including individual details, images or videos), consent to publish must be obtained from that person, or in the case of children, their parent or legal guardian. All presentations of case reports must have consented to publish.
You can use your institutional consent form if you prefer. You should not send the form to us on submission, but we may request to see a copy at any stage (including after publication).
Note: If your manuscript does not contain data from any person, please state “Not applicable” in this section.

Availability of data and materials
All manuscripts must include an ‘Availability of data and materials statement. Data availability statements should include information on where data supporting the results reported in the article can be found including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. By data, we mean the minimal dataset that would be necessary to interpret, replicate and build upon the findings reported in the article. We recognise it is not always possible to share research data publicly, for instance when individual privacy could be compromised, and in such instances, data availability should still be stated in the manuscript along with any conditions for access.
Data availability statements can take one of the following forms (or a combination of more than one if required for multiple datasets):
The datasets generated and/or analysed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]
The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.
All data generated or analysed during this study are included in this published article [and its supplementary information files].
Data sharing does not apply to this article as no datasets were generated or analysed during the current study.
The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].

FJPAS also requires that authors cite any publicly available data on which the conclusions of the paper rely in the manuscript. Data citations should include a persistent identifier (such as a DOI) and should ideally be included in the reference list. Citations of datasets, when they appear in the reference list, should include the minimum information recommended by DataCite and follow journal style. Dataset identifiers including DOIs should be expressed as full URLs. For example:
Hao Z, AghaKouchak A, Nakhjiri N, Farahmand A (2014) Global integrated drought monitoring and prediction system (GIDMaPS) data sets. Figshare.

Competing interests
All financial and non-financial competing interests must be declared in this section.
Please use the authors’ initials to refer to each authors' competing interests in this section.
If you do not have any competing interests, please state "The authors declare that they have no competing interests" in this section.

All sources of funding for the research reported should be declared. The role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.
If no funding is received, the author should state so.

Authors' contributions
The individual contributions of authors to the manuscript should be specified in this section. Please use initials to refer to each author's contribution in this section, for example: "FC analyzed and interpreted the patient data regarding the haematological disease and the transplant. RH performed the histological examination of the kidney and was a major contributor in writing the manuscript. All authors read and approved the final manuscript."

Please acknowledge anyone who contributed towards the article who does not meet the criteria for authorship including anyone who provided professional writing services or materials.
Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements section.
If you do not have anyone to acknowledge, please write "Not applicable" in this section.
Group authorship (for manuscripts involving a collaboration group): if you would like the names of the individual members of a collaboration Group to be searchable through their individual PubMed records, please ensure that the title of the collaboration Group is included on the title page and in the submission system and also include collaborating author names as the last paragraph of the “Acknowledgements” section. Please add authors in the format First Name, Middle initial(s) (optional), Last Name. You can add institution or country information for each author if you wish, but this should be consistent across all authors.
Please note that individual names may not be present in the PubMed record at the time a published article is initially included in PubMed as it takes PubMed additional time to code this information.

Authors' information (this section is optional)
You may choose to use this section to include any relevant information about the author(s) that may aid the reader's interpretation of the article, and understand the standpoint of the author(s). This may include details about the authors' qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe any competing interests.

This should be cited in the text by numbers in brackets in the order of appearance. References should be listed on a separate page and numbered in the same order in which they are cited. References should follow the styles given below.
For Journals:
Liew, K., Yong, P.V.C., Navaratnam, V., Lim, Y.M. and Ho, A.S.H. (2015). Differential analysis on the effects of 2-methoxy-1,4-naphthoquinone towards MDA-MB-231 cell line. Phytomedicine. 22(5): 517-527.
Muzammil, S., Kumar, Y. and Tayyab, S. (1999). Molten. globule-like state of human serum albumin at low pH. Eur. J. Biochem. 266 (1): 26-32.    
 Ajadi, H.M., Nyquist-Battie, B. and Adoluwa, G. (2017) Inhibition of alpha amylase in diabetes induced rats. Biochim. Biophys. Acta. 801(1): 26-31.  
 For books:
Pace, C.N., Shirley, B.A. and Thomson, J.A. (2019). In Protein Structure: A Practical Approach (Creighton,T.E., ed.) Oxford University Press, New York, pp. 311-332.   
All the cited references must be listed at the reference section. The reference must not be more than ten to fifteen years old in the entire manuscript.

Publication Charges
Processing fees: non-refundable fees of N5, 000
Online publication including one hard copy (For only the corresponding authors): N 20,000 or $50

Contact us
Our editorial office is always available to offer support. If you have any questions about editorial duties contact us at or

Editorial office
FUOYE Journal of Pure and Applied Sciences
Office of the Dean, Faculty of Science, Federal University Oye-Ekiti, Ekiti State, Nigeria


Section default policy

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.